The Surprising Turnaround of Pacific Biosciences: What Investors Need to Know Now
PacBio surpassed revenue expectations in Q1 2025 with $37.15 million, despite a 4.3% year-over-year decline. HiFi long-read sequencing, a technological breakthrough, highlights PacBio’s commitment to innovation. Non-GAAP EPS loss narrowed…